123 related articles for article (PubMed ID: 23769048)
1. Posttransplantation systemic immunomodulation with SA-FasL-engineered donor splenocytes has robust efficacy in preventing cardiac allograft rejection in mice.
Zhao H; Woodward KB; Shirwan H; Grimany-Nuno O; Yolcu ES
Transplant Proc; 2013 Jun; 45(5):1805-7. PubMed ID: 23769048
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD mice.
Yolcu ES; Zhao H; Shirwan H
Transplant Proc; 2013 Jun; 45(5):1889-91. PubMed ID: 23769064
[TBL] [Abstract][Full Text] [Related]
3. Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection.
Askenasy N; Yolcu ES; Wang Z; Shirwan H
Circulation; 2003 Mar; 107(11):1525-31. PubMed ID: 12654611
[TBL] [Abstract][Full Text] [Related]
4. Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein.
Yolcu ES; Gu X; Lacelle C; Zhao H; Bandura-Morgan L; Askenasy N; Shirwan H
J Immunol; 2008 Jul; 181(2):931-9. PubMed ID: 18606644
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H
J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235
[TBL] [Abstract][Full Text] [Related]
6. Mouse T cells engineered to display on their surface a novel form of FasL protein undergo apoptosis when stimulated with alloantigens: implications for graft-versus-host disease.
Yolcu ES; Singh NP
Transplant Proc; 2013 Jun; 45(5):1850-2. PubMed ID: 23769056
[TBL] [Abstract][Full Text] [Related]
7. Localized immune tolerance from FasL-functionalized PLG scaffolds.
Skoumal M; Woodward KB; Zhao H; Wang F; Yolcu ES; Pearson RM; Hughes KR; García AJ; Shea LD; Shirwan H
Biomaterials; 2019 Feb; 192():271-281. PubMed ID: 30458362
[TBL] [Abstract][Full Text] [Related]
8. Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease.
Shrestha P; Turan A; Batra L; Gulen AE; Sun Z; Tan H; Askenasy N; Shirwan H; Yolcu ES
Blood Adv; 2023 May; 7(10):2181-2195. PubMed ID: 36780582
[TBL] [Abstract][Full Text] [Related]
9. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
10. Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.
Yolcu ES; Askenasy N; Singh NP; Cherradi SE; Shirwan H
Immunity; 2002 Dec; 17(6):795-808. PubMed ID: 12479825
[TBL] [Abstract][Full Text] [Related]
11. Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
Batra L; Shrestha P; Zhao H; Woodward KB; Togay A; Tan M; Grimany-Nuno O; Malik MT; Coronel MM; García AJ; Shirwan H; Yolcu ES
J Immunol; 2020 May; 204(10):2840-2851. PubMed ID: 32253240
[TBL] [Abstract][Full Text] [Related]
12. Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance.
Headen DM; Woodward KB; Coronel MM; Shrestha P; Weaver JD; Zhao H; Tan M; Hunckler MD; Bowen WS; Johnson CT; Shea L; Yolcu ES; García AJ; Shirwan H
Nat Mater; 2018 Aug; 17(8):732-739. PubMed ID: 29867165
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.
Liu L; Wang F; Zheng Y; Yuan X; Wang D; Zeng W; He X; Wang C; Deng S
Transplant Proc; 2014 May; 46(4):1169-74. PubMed ID: 24815153
[TBL] [Abstract][Full Text] [Related]
14. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
15. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
17. Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model.
Li X; Li JJ; Yang JY; Wang DS; Zhao W; Song WJ; Li WM; Wang JF; Han W; Zhang ZC; Yu Y; Cao DY; Dou KF
PLoS One; 2012; 7(8):e44045. PubMed ID: 22952868
[TBL] [Abstract][Full Text] [Related]
18. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.
Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF
Transplantation; 2000 Oct; 70(7):1068-73. PubMed ID: 11045644
[TBL] [Abstract][Full Text] [Related]
19. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity.
Tokita D; Shishida M; Ohdan H; Onoe T; Hara H; Tanaka Y; Ishiyama K; Mitsuta H; Ide K; Arihiro K; Asahara T
J Immunol; 2006 Sep; 177(6):3615-24. PubMed ID: 16951321
[TBL] [Abstract][Full Text] [Related]
20. FasL is important in costimulation blockade-resistant skin graft rejection.
Trambley J; Lin A; Elwood E; Bingaman AW; Lakkis F; Corbascio M; Pearson TC; Larsen CP
Transplantation; 2001 Feb; 71(4):537-43. PubMed ID: 11258433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
